| Literature DB >> 12627259 |
John Kouvaris1, Vassilis Kouloulias, Elias Malas, Christos Antypas, John Kokakis, Spyros Michopoulos, George Matsopoulos, Lambros Vlahos.
Abstract
AIM: To evaluate the cytoprotective effect of amifostine against radiation-induced acute toxicity to the rectal mucosa. PATIENTS AND METHODS: 36 patients irradiated for prostate or gynecologic cancer were randomized to receive amifostine (n = 18, group A) or not (n = 18, group B). The radiation-induced acute rectal toxicity was evaluated by using three different toxicity scales: WHO scale, EORTC/RTOG toxicity criteria, and a modified toxicity scale based on the LENT-SOMA grading scale and the endoscopic terminology of the World Organization for Digestive Endoscopy. The objective measurements were coming from flexible rectosigmoidoscopy performed at baseline and 1-2 days after completion of the radiotherapy schedule. Anterior-posterior fields were used in the gynecologic patients while 3-D conformal 4-field technique was applied in the prostate cancer patients. The area under the curve (AUC) for dose-volume histograms (DVHs) of the rectum was also assessed during a 3-D treatment planning schedule, and no significant differences were assessed between the two groups, indicating a homogeneous dose-volume effect.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12627259 DOI: 10.1007/s00066-003-0970-y
Source DB: PubMed Journal: Strahlenther Onkol ISSN: 0179-7158 Impact factor: 3.621